HIIT alone cuts insulin resistance in women with PCOS

Polycystic ovary syndrome brings a raised risk of insulin resistance and weight gain, and exercise is one of the first things women with the condition are told to try. What has been less clear is whether high-intensity interval training, short bursts of very hard effort with recovery in between, actually shifts the metabolic markers that matter, or whether any exercise would do the same. Individual trials have been small and their results scattered, which makes pooling them the sensible way to get an answer. This review set out to do exactly that for metabolic outcomes and body composition.

The authors searched eight databases, including Embase, MEDLINE, PubMed and the Cochrane Library, for randomised trials published up to September 2020. Seven trials covering 423 women with PCOS made the cut, comparing HIIT against moderate exercise or a control group. The interval sessions were performed at 90 to 95% of maximum heart rate, three times a week, for at least 10 weeks, and the trials themselves ran for 10 to 16 weeks. Two reviewers independently screened the studies and graded how trustworthy the evidence was, and results were combined with a model that allows for differences between trials.

HIIT produced a significant drop in insulin resistance measured by HOMA-IR, with a pooled reduction of 0.57, backed by moderate certainty evidence. BMI also fell significantly, by 1.90 on the pooled estimate, and here the certainty was rated high. Beyond those two outcomes the picture thins out quickly: the authors judged the evidence too limited to say what HIIT does to other metabolic measures in this population. The included trials were mostly small, averaging 32 participants and ranging from 24 to 110.

Exercise is already a cornerstone of PCOS management, so the contribution here is specificity: HIIT on its own moved insulin resistance and BMI, without needing to be part of a wider programme. That strengthens the case for intervals as a time-efficient option rather than just one flavour of generic activity. The open questions are the ones the authors themselves name: trials longer than 16 weeks, bigger samples, and outcomes beyond HOMA-IR and BMI. Whether HIIT beats moderate exercise head to head also remains unsettled on this evidence.

For a woman with PCOS, this is a reason to think hard interval work earns its place for metabolic health, not only for fitness or calorie burn. The effects were real but modest, and they come from short trials, so this is a lever rather than a cure. It also says nothing against moderate exercise, which some trials used as the comparison; the finding is that HIIT works, not that everything else fails.